A new publication involving vosoritide was listed on October 1, 2026. The article is titled "Early closure of cranial base synchondroses in infants with Vosoritide-treated achondroplasia." It appears in Clinical Pediatric Endocrinology: Case Reports and Clinical Investigations, the official journal of the Japanese Society for Pediatric Endocrinology.
Vosoritide is an approved therapy. This entry reflects the posting of the publication record only. No findings, outcomes, or conclusions from the article are included here beyond the title and journal of record.
Readers interested in the broader context of vosoritide, including its approved indication and regulatory status, can consult the compound overview for additional background information.